Amarin Corp Plc (AMRN)

[HDGabor]

i-

- Latest update: #115214
- Previous was in June / July (after June 23).
- The Complaint was filed on 11/18/2016.
- on 1/10/2017

It is further ordered that the Clerk of Court is directed to consolidate Case Nos. 2:16-cv-02562-RCJ-GWF and 2:16-cv-02658-MMD-GWF with Case No. 2:16-cv-02525-MMD-NJK and all future pleadings must bear Case No. 2:16-cv-02525-MMDNJK.

This case ( 2:17-cv-02641-RFB-VCF ) belongs to the above, is about new ANDA by TEVA (for 500 mg version of V ... 500 mg generic V)

On information and belief and as stated in a letter dated August 29, 2017 sent by Defendants to Amarin (the “August Notice Letter”), Defendants prepared and filed an amendment to ANDA No. 209525 (the “ANDA Amendment”) with the intention of seeking to market a generic version of the 500 mg strength of Amarin’s VASCEPA® product (“generic VASCEPA® 500 mg product”), including within this judicial district.

Upon information and belief, Defendants do business in Nevada through a permanent and continuous presence there.

Best,
G

marzan - "Generic L is ok" ???